Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
A specific and sensitive method for the quantitation of quinidine, (3S)-3-hydroxyquinidine, quinidine N-oxide, and dihydroquinidine in plasma and urine has been developed. The method is based on a single-step, liquid-liquid extraction procedure, followed by isocratic reversed-phase high-performance liquid chromatography, with fluorescence detection. After extraction from 250 microliters plasma and 100 microliters urine, the limit of determination is 10 nM and 25 nM, respectively. For the use as standards, commercially available quinidine was purified from dihydroquinidine; quinidine N-oxide was synthesized.
Department of Clinical Pharmacology, Odense University, Denmark.
F
F
Nielsen
K K
KK
Nielsen
K
K
Brøsen
D002851:Chromatography, High Pressure Liquid; D003497:Cyclic N-Oxides / Q000032:analysis* / Q000097:blood / Q000652:urine; D006801:Humans; D007202:Indicators and Reagents; D009682:Magnetic Resonance Spectroscopy; D010276:Parasympatholytics / Q000032:analysis* / Q000097:blood / Q000652:urine; D011802:Quinidine / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000652:urine; D013050:Spectrometry, Fluorescence
D003497:Cyclic N-Oxides; D007202:Indicators and Reagents; D010276:Parasympatholytics; C013569:3-hydroxyquinidine; C045112:quinidine-N-oxide; C014486:hydroquinidine; D011802:Quinidine